Hotta M, Satake A, Yoshimura H, Fujita S, Katayama Y, Ota S, Hanamoto H, Oyake T, Ito S, Okada M, et al. Elevation of early plasma biomarkers in patients with clinical risk factors predicts the increased nonrelapse mortality after allogeneic hematopoietic stem cell transplantation: Biomarkers for nonrelapse mortality. Transplant Cell Ther. 2021.